Comparative Effectiveness Research—Will the Risks as Well as the Benefits Be Considered?

According to the FDA News, a bill to establish a comparative effectiveness research institute is scheduled for introduction in the Senate. The Comparative Effectiveness Research Act of 2008, sponsored by Sens. Kent Conrad (D-ND) and Max Baucus (D-MT), would evaluate the effectiveness of different drugs and medical devices that exist for the same treatment. The […]

Read More
Why Does the FDA Maintain a Conspiracy of Silence about the Health Benefits of Vitamin D?

Why Does the FDA Maintain a Conspiracy of Silence about the Health Benefits of Vitamin D?

In other vitamin news, British researchers have found that vitamin D may help slow aging—in the study, women with higher vitamin D levels showed fewer aging-related changes in their DNA. Professor Brent Richards, who led the study, said, “This could help to explain how vitamin D has a protective effect on many aging-related diseases, such […]

Read More

Re-importing US Drugs from Foreign Countries a Good Idea, Says Obama’s Healthcare Reform Team

Sen. Byron Dorgan (D-ND) has introduced the Pharmaceutical Market Access and Drug Safety Act, S.525, and twenty-four other senators have already become co-signers. A similar House bill has also been introduced. Both bills allow for the re-importation of cheaper prescription drugs from Canada and other countries. American drug manufacturers sell medicines to foreign countries for […]

Read More